ARF6 and Cirrhosis: Supportive evidence consists of poor ARF6 immunostaining in those liver explants, which manifested bile duct paucity without fibrosis, but not in the remainder, in which advanced cirrhosis with marked cholestasis precluded an evaluation of intrahepatic bile ducts prior to the development of chronic obstructive changes (Fig 1C).